Cell line · CVCL_0037

A-431

Cancer cell line, Homo sapiens. Skin squamous cell carcinoma. 97 papers.

4 sourcescell-lines-2026-11-14-0.1.0

Cite this record

ConductScience Library. A-431. Cell lines, record CVCL_0037. Release cell-lines-2026-11-14-0.1.0, 14 Nov 2026. https://conductscience.org/library/cell-lines/CVCL_0037

On this page

Cell line

As Cellosaurus gives it.

Name: A-431
Accession: CVCL_0037
RRID: RRID:CVCL_0037
Synonyms: A431, A431/P
Species: Homo sapiens (Human)
Sex: Female
Age at sampling: 85Y
Category: Cancer cell line
Diseases: Skin squamous cell carcinoma (NCIt C4819)
Derived from: Skin, epidermis (in situ)
Entry created: 2012-04-04
Entry updated: 2026-06-25

Source Cellosaurus

Problems0

Cellosaurus records no problem for this cell line.

None in this release.

Papers97

Paper	Journal	Year	How we know	Source
Berberine and Etoposide Exert Synergistic Anticancer Effects in A431 Epidermoid Carcinoma Cells.	ACS Omega	2026	Its Methods give the RRID and name the line	PubMed
A guide to selecting high-performing antibodies for Netrin-1 (UniProt ID: O95631) for use in western blot and immunoprecipitation.	F1000Res	2026	Its Methods give the RRID and name the line	PubMed
Oral Fungal Infection Impacts Epithelial Innate Immunity to Promote Local and Distal Squamous Cell Carcinoma Progression.	Cancer Res	2026	Its Methods give the RRID and name the line	PubMed
Volume EM reveals desmosome three-dimensional architecture in epithelial cells and tissue models.	J Cell Biol	2026	Its Methods give the RRID and name the line	PubMed
Lipid packing contributes to the confinement of caveolae to the plasma membrane.	Elife	2026	Its Methods give the RRID and name the line	PubMed
PHF20 stabilizes the GAS7-F-actin axis to drive DNA damage repair and chemoresistance in cutaneous squamous cell carcinoma.	Cell Death Dis	2026	Its Methods give the RRID and name the line	PubMed
BLU-451, a CNS-Active, Potent, and Selective Small-Molecule Inhibitor against Uncommon EGFR Mutations.	Mol Cancer Ther	2026	Its Methods give the RRID and name the line	PubMed
A Moderate-Affinity Antibody-Drug Conjugate Targeting B7-H3 Exerts Potent Antitumor Efficacy.	Pharmaceuticals (Basel)	2026	Its Methods give the RRID and name the line	PubMed
Quantification of Antibody-Drug Conjugate Targets in Head and Neck Squamous Cell Carcinoma.	Mol Cancer Ther	2026	Its Methods give the RRID and name the line	PubMed
KLS-3021: Innovative oncolytic virotherapy for the treatment of advanced primary and metastatic cutaneous squamous cell carcinoma.	Mol Ther Oncol	2026	Its Methods give the RRID and name the line	PubMed

1 to 10 of 97

See all 97 papers

Relatives63

Relation	Cell line	Accession	Source
Derived from it	A-431-Luc	CVCL_C8WW	Cell lines
Derived from it	A-431-Luc2	CVCL_A4BS	Cell lines
Derived from it	A-431-SF	CVCL_C8Z1	Cell lines
Derived from it	A431 GR	CVCL_E4DP	Cell lines
Derived from it	A431 YAP-5SA	CVCL_QX12	Cell lines
Derived from it	A431 siYAP	CVCL_QX11	Cell lines
Derived from it	A431-AC3	CVCL_B5YD	Cell lines
Derived from it	A431-PR	CVCL_EQ67	Cell lines
Derived from it	A431/CDDP1	CVCL_GY97	Cell lines
Derived from it	A431/CDDP2	CVCL_GY98	Cell lines

1 to 10 of 63

See all 63 relatives

Cell banks25

Cell bank	Catalog number	Status	Source
ATCC	CRL-1555		ATCC
ATCC	CRL-7907	Discontinued	Cellosaurus
Abcam	ab263975		Abcam
Abcam	ab275462		Abcam
AddexBio	C0012001/22		Cellosaurus
BCRC	60161		BCRC
BCRJ	0032		BCRJ
CCTCC	GDC0084		Cellosaurus
CLS	300112		CLS
DSMZ	ACC-91		DSMZ

1 to 10 of 25

See all 25 cell banks

Data dates

The date of each source this release read.

Cellosaurus: 2026-10-22; Cellosaurus
PubMed Central's articles: 2026-11-12; PubMed Central's articles
Our copy of PubMed: 2026-11-06; Our copy of PubMed

Sources 4

CellosaurusCC BY 4.0, with credit to Cellosaurus (SIB)
PubMed Central's articlesTitles shown only for CC0, CC BY and public domain articles
NLM's PMC Article DatasetsCourtesy of NLM, which does not endorse this database
PubMedNLM's terms

Each source's terms

CellosaurusCC BY 4.0. Cellosaurus's README: "we have chosen to apply the Creative Commons Attribution 4.0 International (CC BY 4.0) license to Cellosaurus (https://creativecommons.org/licenses/by/4.0/). This means that you are free to copy and redistribute Cellosaurus in any medium or format. You can remix, transform, and build upon Cellosaurus for any purpose, even commercially. You must give appropriate credit, provide a link to the license, and indicate if changes were made." Copyright (c) CALIPHO group, SIB Swiss Institute of Bioinformatics. Read on 14 Nov 2026 at https://ftp.expasy.org/databases/cellosaurus/README
PubMed Central's articlesEach article's own license. Its words show only under CC0, CC BY or public domain
NLM's PMC Article DatasetsNLM's PMC Article Datasets on AWS, https://registry.opendata.aws/ncbi-pmc. Its terms: users "acknowledge NLM as the source of the data in a clear and conspicuous manner", do not use the PubMed Central wordmark or the PMC logo, do not "indicate or imply that NLM/NIH/HHS has endorsed" a product, and "only distribute data that are licensed for redistribution". Each article keeps its own license: https://pmc.ncbi.nlm.nih.gov/about/copyright/
PubMedNLM's terms

Cellosaurus, SIB Swiss Institute of Bioinformatics, https://www.cellosaurus.org, CC BY 4.0. Its problem notes are given in its own words.

For software

Read this cell line from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/cell-lines/v1/CVCL_0037

GET https://conductscience.org/api/cell-lines/v1/CVCL_0037/papers?page=2

API reference For AI assistants